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The chiral title compound, C16H20N2O2, which can be used for producing active
pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and
other pathologies dependent on insulin resistance, was prepared from (1R,3S)-
camphoric acid and o-phenylenediamine. It crystallized from an ethanol solution
in the chiral monoclinic P21 space group. The five-membered ring adopts a
twisted conformation with the methyl-substituted C atoms displaced by
0.273 (5) and 0.407 (5) Å from the mean plane through the other three atoms.
In the crystal, molecules are linked by O—H  N hydrogen bonds, forming
chains along the a-axis direction. Hirshfeld surface analysis and two-dimensional
fingerprint plots were used to analyze the intermolecular contacts present in the
crystal.
1. Chemical context
The incidence of diabetes has taken on the character of an
epidemic in the world. According to the forecasts of the World
Health Organization, the number of patients with diabetes will
double and reach 300 million people by 2025 (Zimmet et al.,
2001). In this regard, developing and introducing new anti-
diabetic drugs is of great importance.
A great number of camphoric acid as well as benzimidazole
derivatives exhibit different types of biological activities
(Merzlikin et al., 2008; Ivachtchenko et al., 2002, 2019; Kova-
lenko et al., 1998).
Our research on the molecular design, construction and
synthesis of new benzimidazole derivatives of 1,2,2,3-tetra-
methylcyclopentane-1-carboxylic acid has shown that (1R,3S)-
3-(1H-benzo[d]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-
carboxylic acid, 4, exhibits pronounced antidiabetic activity
and, in particular, antihyperglycemic effect, which reduces
insulin resistance and restores the physiological function of
pancreatic -cells (Jain et al., 2009; Chuev et al., 2017).
ISSN 2056-9890
Racemic and enantiomeric crystals are known to possess
different activities, which is very important in the pharma-
ceutical industry. We have found that the disadvantage of the
() and (-) forms of compound 4 described in the patent of
Merzlikin et al. (2009) is their poor bioavailability as compared
to the (+) form. To obtain (1R,3S)-3-(1H-benzo[d] imidazol-2-
yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid 4, the
enantiomerically pure (1R,3S)-camphoric acid 1 was used.
In the first stage, (1R,5S)-1,8,8-trimethyl-3-oxabi-
cyclo[3.2.1]octane-2,4-dione [d-(+)-camphoric anhydride] 2
was obtained by refluxing a mixture of (1R,3S)-camphoric acid
and acetic anhydride for 2 h (Dong et al., 2016) (Fig. 1).
In the second stage, the synthesis of (1R,3S)-3-(1H-
benzo[d]imidazol-2-yl)-1,2,2- trimethylcyclopentane-1-carb-
oxylic acid 4 was carried out according to Fig. 2 via cyclo-
condensation of d-(+)-camphoric anhydride 2 with o-
phenylenediamine 3 in a mixture of toluene and DMF (383 K)
by refluxing for several hours (Fig. 2).
It should be noted that during the synthesis, the config-
uration of the chiral centers did not change and the structure
of the title molecule was unambiguously confirmed by X-ray
analysis.
2. Structural commentary
The asymmetric unit contains one molecule of the title
compound 4 (Fig. 3). The bicyclic fragment is planar with a
maximum deviation of 0.016 (6) Å (for atom C16). The satu-
rated five-membered ring adopts a twisted conformation in
which the deviations of atoms C11 and C12 from the mean-
square plane through the remaining ring atoms are 0.273 (5)
and 0.407 (5) Å, respectively. The cyclopentane ring is turned
in relation to the N1—C1 endocyclic bond, the N1—C1—C8—
C9 torsion angle being 30.0 (7). It can be assumed that the
weak intramolecular C9—H9B  N1 (H  N = 2.53 Å, C—
H  N = 108) hydrogen bond additionally stabilizes such a
location of the saturated ring. The methyl group on the C11
atom is located in the axial position [C9—C10—C11—C15 =
87.5 (6)]. The carboxyl group has an equatorial orientation
and is almost coplanar to the endocyclic C10–C11 bond [the
C9—C10—C11—C16 and C10—C11—C16—O1 torsion
angles are 150.8 (5) and 13.9 (8), respectively]. This posi-
tion is stabilized by the formation of weak intramolecular
C10—H10A  O1 and C15—H15B  O2 hydrogen bonds
between the vicinal and geminal substituents (H  O = 2.43
and 2.42 Å, C—H  O = 103 and 100, respectively). The
presence of geminal substituents on neighboring atoms of the
pentane ring leads to significant steric repulsion (the shor-
tened intramolecular contacts are given in Table 1), which
causes elongation of the C8—C12 bond to 1.571 (7) Å,
compared with its mean value of 1.556 Å (Burgi et al., 1994).
3. Supramolecular features
In the crystal, molecules of 4 form layers parallel to the (100)
plane as a result of the strong N2—H  O1 and O2—H  N1
and weak C14—H14C  C2() intermolecular hydrogen
bonds (Table 2, Fig. 4a,b). The neighboring layers are not
bound any specific interactions (Fig. 4a). It is interesting to
note that the molecules are linked by hydrogen bonds that use
the O—H  N heterosynthon instead of the carboxylic acid
dimer homosynthon. Despite the presence of an aromatic ring
in the molecule, no stacking interactions are observed in the
crystal of 4. Instead of –  interactions, C—H   inter-
actions are formed (Table 2, Fig. 4b).
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Figure 2
Synthesis of (1R,3S)-3-(1H-benzo[d]imidazol-2-yl)-1,2,2- trimethylcyclo-
pentane-1-carboxylic acid, 4.
Figure 3
The molecular structure of the title compound 4 with the atom labeling.
Displacement ellipsoids are drawn at the 50% probability level.
Table 1
Intramolecular short contacts (Å) in compound 4 together with the sums
of the respective van der Waals radii.
The van der Waals radii sum values (Zefirov et al., 1997) are given in
parentheses.
H8  H15A 2.26 (2.34) H15B  H14C 2.32 (2.34)
H13C  C1 2.57 (2.87) H13B  C16 2.54 (2.87)
Table 2
Hydrogen-bond geometry (Å, ).
D—H  A D—H H  A D  A D—H  A
O2—H2  N1i 0.82 1.82 2.631 (6) 170
N2—H2A  O1ii 0.86 2.16 2.871 (6) 140




4. Hirshfeld surface analysis
Crystal Explorer 17.5 (Turner et al., 2017) was used to analyze
the interactions in the crystal and fingerprint plots mapped
over dnorm (Figs. 5 and 6) were generated. The molecular
Hirshfeld surfaces were obtained using a standard (high)
surface resolution with the three-dimensional dnorm surfaces
mapped over a fixed color scale of0.716 (red) to 1.406 (blue)
a.u. The red spots indicate regions of donor–acceptor inter-
actions or short contacts. There are three red spots in the dnorm
surface for 4 (Fig. 5), which correspond to the interactions
listed in Table 2.
All of the intermolecular interactions of the title compound
are shown in the two-dimensional fingerprint plot presented in
Fig. 6a. The fingerprint plots indicate that the principal
contributions are from H  H (61.7%; Fig. 6b), C  H/H  C
(18.1%; Fig. 6c), O  H/H  O (13.5%; Fig. 6d) and N  H/
H  N (6.6%; Fig. 6e) contacts. The H  H interactions appear
in the middle of the plot scattered over a large area, while the
C  H/H  C contacts are represented by the ‘wings’ of the
plot. O  H/H  O interactions appear as inner spikes and the
N  H/H  N contacts, corresponding to the O—H  N
interaction, are represented by a pair of sharp outer spikes,
which indicate they are the strongest interactions in the crystal
of 4.
5. Database survey
A search of the Cambridge Structural Database (CSD,
Version 5.41, November 2019; Groom et al., 2016) for the
1,2,2-trimethylcyclopentane-1-carboxylic acid skeleton
yielded 27 hits. Only one structure involves a benzothiazol-20-
yl ring in position 3, viz. (1R,3S)-(+)-cis-1,3-bis(benzothiazol-
20-yl)-1,2,2-trimethylcyclopentane (CSD refcode XUMXIM;
Gilbert et al., 2002). The cyclopentane ring has the twist
conformation with the atoms C1 and C4 displaced by 0.48 (1)
and 0.26 (2) Å from the mean plane through the other three
atoms [cf. 0.407 (5) Å and 0.273 (5) Å in the title
compound].
6. Synthesis and crystallization
(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-trimethylcyclo-
pentane-1-carboxylic acid, 4
In a glass reactor equipped with a Dean–Stark receiver,
d-(+)-camphoric anhydride 2 (2.20 kg, 12.1 mol), o-phenyl-
enediamine 3 (1.31 kg, 12.1 mol), toluene (11.46 L) and di-
methylformamide (0.91 L) were charged. Under stirring, the
reaction mixture was heated to boiling (383 K). The mixture
was refluxed and the released water was collected in the
Dean–Stark receiver. When the removal of water had finished,
the reaction mixture was cooled to room temperature. The
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Figure 5
Two orientations of the Hirshfeld surface for the title compound mapped
over dnorm.
Figure 6
(a) The two-dimensional fingerprint plot for compound 4, and those
delineated into (b) H  H (61.7%), (c) C  H/H  C (18.1%), (d) O  H/
H  O (13.5%) and (e) N  H/H  N (6.6%) contacts.
Figure 4
(a) View of the structure of compound 4 down the b axis and (b) hydrogen bonds within a layer in the crystal of 4.
precipitate that formed was filtered in vacuo using a Nutsche
filter. The precipitate was thoroughly squeezed, washed twice
with toluene (1.4 L) and re-squeezed. Then the precipitate was
washed on the filter with 70% water–ethanol (3.7 L), heated to
a temperature of 3485 K. Finally, the precipitate of the
product 4 was thoroughly squeezed and dried at 343 K for 4 h,
yielding 2.41 kg (73.2%) of a white crystal-like powder that is
practically insoluble in water, soluble in 96% alcohol, m.p.
527–528 K. UV (ethanol) max ("): 204 nm (48960), 245 nm
(6800), 275 nm (9160), 281 nm (9320); IR (KBr):  (cm1)
3450 (O—H), 3286 (N—H), 2970, 2935, 2887 (C—H), 1673
(C O), 1529, 1456, 1436, 1373, 1279, 1358, 1167, 1124, 1057,
740; 1H NMR (400 MHz, DMSO-d6)  12.22 (s.br, 1H, OH),
12.10 (s.br, 1H, NH), 7.52 (s.br, 1H, H-4, H-7), 7.44 (s.br, 1H,
H-4, H-7), 7.10 (t, J = 4.5 Hz, 2H, H-5, H-6), 3.41–3.31 (m, 1H,
CH), 2.64–2.54 (m, 1H,CH), 2.43–2.33 (m, 1H, CH), 2.05–1.95
(m, 1H, CH), 1.55–1.45 (m, 1H, CH), 1.25 (s, 3H, CH3), 1.14 (s,
3H, CH3), 0.61 (s, 3H, CH3); LC/MS m/z (%): 273.2 [MH]+
(100); found, %: C 70.88; H 7.83; N 10.55. C16H20N2O2.
Calculated, %: C 70.56; H 7.40; N 10.29.
Further crystallization by slow evaporation of an ethanol
solution was carried out to provide single block-like colorless
crystals (Fig. 7) suitable for X-ray diffraction analysis.
7. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 3. H atoms were included in calcu-
lated positions and treated as riding on their parent C atom:
C—H = 0.82–0.98 Å with Uiso(H) = 1.5Ueq(C-methyl and O-
hydroxyl) and 1.2Ueq(C) for other H atoms. The Flack para-
meter cannot be determined reliably, because there is no
X-ray anomalous scattering because of the absence of heavy
atoms in the molecule.
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Crystal system, space group Monoclinic, P21
Temperature (K) 293
a, b, c (Å) 7.9805 (7), 10.8671 (8), 8.4912 (7)
 () 94.056 (7)
V (Å3) 734.55 (10)
Z 2
Radiation type Mo K
 (mm1) 0.08
Crystal size (mm) 0.3  0.2  0.1
Data collection
Diffractometer Rigaku Oxford Diffraction
Xcalibur, Sapphire3
Absorption correction Multi-scan (CrysAlis PRO; Rigaku
OD, 2018)
Tmin, Tmax 0.182, 1.000
No. of measured, independent and







R[F 2 > 2	(F 2)], wR(F 2), S 0.065, 0.180, 1.04
No. of reflections 2455
No. of parameters 185
No. of restraints 1
H-atom treatment H-atom parameters constrained
max, min (e Å
3) 0.15, 0.19
Absolute structure Flack x determined using 459
quotients [(I+)(I)]/[(I+)+(I)]
(Parsons et al., 2013)
Absolute structure parameter 1.8 (10)
Computer programs: CrysAlis PRO (Rigaku OD, 2018), SHELXT (Sheldrick, 2015a),
SHELXL (Sheldrick, 2015b), OLEX2 (Dolomanov et al., 2009).
Figure 7
Crystals of the title compound 4.
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Computing details 
Data collection: CrysAlis PRO (Rigaku OD, 2018); cell refinement: CrysAlis PRO (Rigaku OD, 2018); data reduction: 
CrysAlis PRO (Rigaku OD, 2018); program(s) used to solve structure: ShelXT (Sheldrick, 2015a); program(s) used to 
refine structure: SHELXL (Sheldrick, 2015b); molecular graphics: OLEX2 (Dolomanov et al., 2009); software used to 






a = 7.9805 (7) Å
b = 10.8671 (8) Å
c = 8.4912 (7) Å
β = 94.056 (7)°
V = 734.55 (10) Å3
Z = 2
F(000) = 292
Dx = 1.231 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 748 reflections
θ = 3.6–20.3°
µ = 0.08 mm−1
T = 293 K
Plate, colourless
0.3 × 0.2 × 0.1 mm
Data collection 
Rigaku Oxford Diffraction Xcalibur, Sapphire3 
diffractometer
Radiation source: fine-focus sealed X-ray tube, 
Enhance (Mo) X-ray Source
Graphite monochromator
Detector resolution: 16.1827 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlisPro; Rigaku OD, 2018)
Tmin = 0.182, Tmax = 1.000
4859 measured reflections
2455 independent reflections
1731 reflections with I > 2σ(I)
Rint = 0.058













Primary atom site location: dual
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0794P)2] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.15 e Å−3
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Δρmin = −0.19 e Å−3 Absolute structure: Flack x determined using 
459 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 
2013)
Absolute structure parameter: −1.8 (10)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
O1 0.3639 (6) 0.5406 (4) 0.7106 (5) 0.0801 (12)
O2 0.2632 (6) 0.7051 (3) 0.5806 (5) 0.0755 (12)
H2 0.289977 0.738749 0.665107 0.113*
N1 0.6692 (5) 0.3376 (4) 0.1635 (5) 0.0593 (11)
N2 0.5767 (6) 0.4717 (4) −0.0168 (5) 0.0673 (13)
H2A 0.510294 0.522765 −0.067258 0.081*
C1 0.5454 (7) 0.4112 (5) 0.1190 (6) 0.0584 (13)
C2 0.7894 (7) 0.3527 (5) 0.0550 (7) 0.0604 (14)
C3 0.7336 (8) 0.4365 (5) −0.0588 (7) 0.0654 (14)
C4 0.8269 (10) 0.4678 (6) −0.1848 (8) 0.0831 (19)
H4 0.786965 0.523797 −0.261269 0.100*
C5 0.9807 (11) 0.4124 (8) −0.1914 (9) 0.096 (2)
H5 1.047951 0.432369 −0.272757 0.115*
C6 1.0379 (9) 0.3261 (7) −0.0773 (9) 0.090 (2)
H6 1.142413 0.289532 −0.084821 0.108*
C7 0.9429 (8) 0.2942 (7) 0.0460 (8) 0.0759 (17)
H7 0.980342 0.235604 0.120267 0.091*
C8 0.3928 (7) 0.4359 (5) 0.2036 (6) 0.0580 (13)
H8 0.300846 0.455808 0.125078 0.070*
C9 0.3372 (7) 0.3271 (5) 0.3025 (7) 0.0679 (15)
H9A 0.245558 0.283181 0.246369 0.082*
H9B 0.429868 0.270412 0.324145 0.082*
C10 0.2806 (9) 0.3803 (5) 0.4556 (8) 0.0716 (16)
H10A 0.360495 0.359711 0.543071 0.086*
H10B 0.171604 0.347548 0.477382 0.086*
C11 0.2707 (6) 0.5205 (5) 0.4334 (7) 0.0597 (14)
C12 0.4144 (6) 0.5465 (5) 0.3225 (6) 0.0575 (12)
C13 0.5865 (7) 0.5408 (6) 0.4150 (7) 0.0707 (15)
H13A 0.597970 0.463626 0.469595 0.106*
H13B 0.595652 0.606974 0.490044 0.106*
H13C 0.673547 0.548409 0.343119 0.106*
C14 0.3983 (9) 0.6692 (5) 0.2366 (8) 0.0764 (17)
H14A 0.491174 0.679383 0.171902 0.115*
H14B 0.398423 0.734744 0.312382 0.115*
H14C 0.295039 0.670837 0.171336 0.115*
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C15 0.0964 (7) 0.5560 (7) 0.3588 (8) 0.0811 (18)
H15A 0.079109 0.518462 0.256632 0.122*
H15B 0.089416 0.643848 0.348102 0.122*
H15C 0.011624 0.527941 0.425166 0.122*
C16 0.3042 (6) 0.5877 (5) 0.5895 (7) 0.0612 (15)
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.100 (3) 0.086 (3) 0.053 (2) 0.005 (2) −0.011 (2) 0.006 (2)
O2 0.103 (3) 0.063 (2) 0.058 (3) 0.012 (2) −0.014 (2) −0.0111 (18)
N1 0.067 (3) 0.060 (3) 0.051 (3) 0.004 (2) 0.001 (2) 0.001 (2)
N2 0.083 (3) 0.067 (3) 0.050 (3) 0.003 (2) −0.004 (2) 0.006 (2)
C1 0.070 (3) 0.060 (3) 0.043 (3) −0.001 (3) −0.006 (2) −0.001 (2)
C2 0.063 (3) 0.066 (3) 0.051 (3) −0.002 (3) 0.000 (2) −0.006 (3)
C3 0.078 (4) 0.063 (3) 0.055 (3) −0.010 (3) 0.004 (3) −0.005 (3)
C4 0.104 (5) 0.088 (4) 0.059 (4) −0.026 (4) 0.016 (3) −0.001 (3)
C5 0.098 (5) 0.119 (6) 0.073 (5) −0.039 (5) 0.027 (4) −0.019 (4)
C6 0.075 (4) 0.113 (6) 0.083 (5) −0.011 (4) 0.012 (4) −0.026 (5)
C7 0.071 (4) 0.090 (4) 0.066 (4) 0.000 (3) 0.001 (3) −0.011 (3)
C8 0.068 (3) 0.056 (3) 0.049 (3) 0.002 (2) −0.007 (2) −0.002 (2)
C9 0.074 (4) 0.055 (3) 0.074 (4) −0.001 (3) 0.003 (3) −0.001 (3)
C10 0.088 (4) 0.061 (3) 0.066 (4) −0.005 (3) 0.008 (3) 0.005 (3)
C11 0.056 (3) 0.055 (3) 0.067 (4) 0.003 (2) −0.004 (2) 0.000 (3)
C12 0.061 (3) 0.052 (3) 0.058 (3) 0.001 (2) −0.002 (2) 0.003 (2)
C13 0.064 (3) 0.071 (3) 0.075 (4) 0.000 (3) −0.005 (3) −0.010 (3)
C14 0.102 (5) 0.058 (3) 0.069 (4) 0.007 (3) 0.003 (3) 0.007 (3)
C15 0.063 (3) 0.097 (4) 0.081 (4) 0.005 (4) −0.012 (3) −0.019 (4)
C16 0.057 (3) 0.068 (4) 0.058 (4) 0.001 (3) 0.001 (3) −0.005 (3)
Geometric parameters (Å, º) 
O1—C16 1.216 (6) C5—C6 1.401 (11)
O2—C16 1.319 (6) C6—C7 1.380 (9)
N1—C1 1.307 (7) C8—C9 1.533 (8)
N1—C2 1.386 (7) C8—C12 1.571 (7)
N2—C1 1.366 (7) C9—C10 1.520 (9)
N2—C3 1.381 (8) C10—C11 1.536 (8)
C1—C8 1.481 (8) C11—C12 1.560 (8)
C2—C3 1.378 (8) C11—C15 1.537 (7)
C2—C7 1.387 (8) C11—C16 1.520 (8)
C3—C4 1.388 (8) C12—C13 1.534 (7)
C4—C5 1.372 (10) C12—C14 1.521 (8)
C1—N1—C2 106.3 (5) C10—C9—C8 106.8 (5)
C1—N2—C3 107.9 (5) C9—C10—C11 106.7 (5)
N1—C1—N2 111.0 (5) C10—C11—C12 102.7 (4)
N1—C1—C8 127.0 (5) C10—C11—C15 109.7 (5)
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N2—C1—C8 121.9 (5) C15—C11—C12 112.9 (5)
N1—C2—C7 129.6 (6) C16—C11—C10 111.4 (5)
C3—C2—N1 109.9 (5) C16—C11—C12 110.4 (4)
C3—C2—C7 120.5 (6) C16—C11—C15 109.7 (4)
N2—C3—C4 132.6 (6) C11—C12—C8 101.4 (4)
C2—C3—N2 104.9 (5) C13—C12—C8 110.6 (4)
C2—C3—C4 122.5 (6) C13—C12—C11 110.7 (4)
C5—C4—C3 117.0 (7) C14—C12—C8 111.1 (4)
C4—C5—C6 120.9 (6) C14—C12—C11 114.0 (5)
C7—C6—C5 121.6 (7) C14—C12—C13 108.8 (5)
C6—C7—C2 117.5 (7) O1—C16—O2 122.4 (5)
C1—C8—C9 113.9 (5) O1—C16—C11 124.8 (5)
C1—C8—C12 113.2 (4) O2—C16—C11 112.8 (5)
C9—C8—C12 105.1 (4)
N1—C1—C8—C9 −30.0 (7) C7—C2—C3—N2 177.5 (5)
N1—C1—C8—C12 90.0 (6) C7—C2—C3—C4 −1.0 (8)
N1—C2—C3—N2 −0.1 (6) C8—C9—C10—C11 10.7 (7)
N1—C2—C3—C4 −178.6 (5) C9—C8—C12—C11 −35.1 (5)
N1—C2—C7—C6 179.1 (5) C9—C8—C12—C13 82.4 (6)
N2—C1—C8—C9 153.8 (5) C9—C8—C12—C14 −156.6 (5)
N2—C1—C8—C12 −86.2 (6) C9—C10—C11—C12 −32.7 (6)
N2—C3—C4—C5 −178.8 (6) C9—C10—C11—C15 87.5 (6)
C1—N1—C2—C3 −1.0 (6) C9—C10—C11—C16 −150.8 (5)
C1—N1—C2—C7 −178.3 (6) C10—C11—C12—C8 41.1 (5)
C1—N2—C3—C2 1.1 (6) C10—C11—C12—C13 −76.3 (5)
C1—N2—C3—C4 179.4 (6) C10—C11—C12—C14 160.6 (5)
C1—C8—C9—C10 140.0 (5) C10—C11—C16—O1 13.9 (8)
C1—C8—C12—C11 −160.0 (4) C10—C11—C16—O2 −166.9 (5)
C1—C8—C12—C13 −42.5 (6) C12—C8—C9—C10 15.6 (6)
C1—C8—C12—C14 78.5 (6) C12—C11—C16—O1 −99.5 (6)
C2—N1—C1—N2 1.7 (6) C12—C11—C16—O2 79.7 (5)
C2—N1—C1—C8 −174.8 (5) C15—C11—C12—C8 −76.9 (5)
C2—C3—C4—C5 −0.8 (9) C15—C11—C12—C13 165.7 (5)
C3—N2—C1—N1 −1.8 (6) C15—C11—C12—C14 42.6 (6)
C3—N2—C1—C8 174.9 (5) C15—C11—C16—O1 135.5 (6)
C3—C2—C7—C6 2.0 (8) C15—C11—C16—O2 −45.3 (7)
C3—C4—C5—C6 1.4 (10) C16—C11—C12—C8 160.0 (4)
C4—C5—C6—C7 −0.4 (10) C16—C11—C12—C13 42.6 (6)
C5—C6—C7—C2 −1.3 (9) C16—C11—C12—C14 −80.5 (5)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
O2—H2···N1i 0.82 1.82 2.631 (6) 170
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N2—H2A···O1ii 0.86 2.16 2.871 (6) 140
C14—H14C···C2iii 0.96 2.81 3.439 (8) 124
Symmetry codes: (i) −x+1, y+1/2, −z+1; (ii) x, y, z−1; (iii) −x+1, y+1/2, −z.
